Angewandte
Chemie
DOI: 10.1002/anie.201201720
High-Throughput Screening
Rapid Catalyst Identification for the Synthesis of the Pyrimidinone
Core of HIV Integrase Inhibitors**
Ana Bellomo, Nihan Celebi-Olcum, Xiaodong Bu, Nelo Rivera, Rebecca T. Ruck,
Christopher J. Welch, Kendall N. Houk,* and Spencer D. Dreher*
Microscale multiparallel chemistry platform technologies
enable modern synthetic chemists to rapidly apply known
potential solutions for a given synthetic transformation to
new, high-complexity synthetic problems. This paradigm is
typically most successful for solving problems where a rich
history of relevant literature precedents and a thorough
mechanistic understanding of the target reaction already
exist. For example, a Suzuki reaction platform employing an
array of known effective phosphine ligands, reaction solvents,
and inorganic bases can be screened to uncover optimal
substrate-specific reaction conditions with a high probability
of success. However, many synthetic problems arise for which
rationally designed platforms are not available, and cannot be
designed owing to a lack of precedent or understanding.
Nevertheless, microscale high-throughput experimentation
(HTE) tools can be used to maximize the opportunity to
serendipitously improve reaction performance, and several
recent, high-profile reports have highlighted some initial
progress in this area.[1–8]
Herein, we describe a broad-based, microscale additive-
screening platform that was designed to minimize complexity
and cost/time bottlenecks in the discovery of new ways to
improve the performance for a wide variety of reactions. By
using this approach, a single chemist was able to set up and
analyze 475 different reaction conditions in a single day to
identify new catalysts for the preparation of high-value
pyrimidinone heterocycles, which are at the core of HIV
Integrase inhibitors.[9,10] Follow-up investigations of identified
conditions combined with quantum mechanical calculations
led to the proposal of a single-electron transfer (SET)
activation mechanism for this catalysis, thus illustrating how
the pursuit of serendipitous solutions can sometimes lead to
improved understanding.
We envisioned creating a 96-well plate additives platform
containing 95 different, highly practical pre-dosed com-
pounds which might activate a reaction through a variety of
different mechanistic pathways; there was one empty well for
a comparative control reaction. The additives that were
chosen are displayed in Figure S1 of the Supporting Informa-
tion. Ideally, this reaction improvement engine would be
inexpensive and simple to use, while providing results that
would be a robust predictor of scale-up performance. To
minimize reagent cost, we utilized very small 250 mL HPLC-
vial inserts (microvials)[11] as reaction vials, thus permitting
reaction screening at approximately 20 mL of solvent (ca.
1 mg substrate per reaction). This is about 4–5 times smaller
than the 1 mL vials that are the current HTE standard in
industry and academic laboratories, and in our opinion
represents the present lower limit that still enables robust
chemistry development. The platform setup simply requires
weighing out the substrates, reagents, and solvent into a single
vial, then distributing this mixture to the additives plate using
a pipettor, a process that only takes a few minutes to
complete. Finally, after reaction incubation, we envisioned
using MISER chromatography[12,13] for sample analysis, as this
method enables an entire 96-well plate to be evaluated in
about 1 hour, and produces a convenient graphical output that
facilitates hit identification.
We were interested in applying this platform to the
synthesis of 2-substituted-5-hydroxy-6-oxo-1,6-dihydropyri-
midine-4-carboxylic acid (pyrimidinone) derivatives of type
2 (Scheme 1), an important class of compounds with well-
documented biological activity.[9,10,14–16] Currently, the most
effective approach for the synthesis of pyrimidinones employs
a two-step process which involves a Michael addition of an N-
hydroxy amidine to an acetylynic diester with a subsequent
[*] Dr. A. Bellomo
Department of Chemistry, University of Pennsylvania
Philadelphia, PA 19104-6323 (USA)
Dr. N. Celebi-Olcum, Prof. Dr. K. N. Houk
Department of Chemistry and Biochemistry, University of California
Los Angeles, CA 90095 (USA)
E-mail: houk@chem.ucla.edu
Dr. X. Bu, Dr. N. Rivera, Dr. R. T. Ruck, Dr. C. J. Welch,
Dr. S. D. Dreher
Department of Process Chemistry, Merck Research Laboratories
P.O. Box 2000, Rahway, NJ 07065 (USA)
E-mail: spencer_dreher@merck.com
[**] We thank the following individuals from the Merck Research
Laboratories: T. J. Novak for his help in obtaining HRMS data and
Rosemary Marques for assistance with IR. A.B. thanks the NSF
GOALI program for financial support.
Scheme 1. Catalyst screening for the synthesis of pyrimidinone 2a
from Michael adduct 1a using the additive platform. The pyrimidone
core is highlighted in red. A MISER chromatogram for the 96 reactions
run in 1,4-dioxane reveals which additives resulted in significant
product formation (highlighted in green).
Supporting information for this article (general synthetic proce-
dures, 1H and 13C NMR and HPLC data for compounds listed in all
tables, and MISER data) is available on the WWW under http://dx.
Angew. Chem. Int. Ed. 2012, 51, 1 – 5
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1
These are not the final page numbers!